During the forecast period 2023 to 2033, the Eosinophilia therapeutics market is expected to grow at a value of 6% CAGR, according to Future Market Insights. By the year 2033, the global market for Eosinophilia therapeutics is expected to rise up to a market valuation of US$ 739.62 Million. Growth of the market can be attributed to …
Category Archives: Healthcare Trends
Antibody-mediated Rejection Prevention Market is expected to be valued at US$ 89 million in 2023
The global antibody-mediated rejection prevention market is predicted to reach a valuation of US$ 89 million in 2023, with a compound annual growth rate (CAGR) of 16%, as per a recently published FMI report. Over the last decade, the complement system has emerged as an important constituent of the AMR market. Technological innovations, such as genomic research and …
Uterine Manipulation Devices Market accounted for an absolute dollar opportunity of nearly US$ 255.2 Million from 2023 to 2033
The Uterine Manipulation Devices market revenues were estimated at US$ 297.7 Million in 2022 and is anticipated to grow at a CAGR of 6.1% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 570.3 Million. The aggregate revenue from the US, …
Healthcare Regulatory Affairs Outsourcing Market at a CAGR of 11.3% during the period 2023 to 2033
The healthcare regulatory affairs outsourcing market size is expected to reach a valuation of US$ 5.8 Billion by 2033. As of 2023, the market is valued at US$ 2 Billion, and is expected to grow at a CAGR of 11.3% during the forecast period. The surging number of cases pertaining to chronic ailments and increased …
Clinical Alarm Management Market is expected to surpass US$ 6.2 billion by 2033 at a CAGR 7.5%
The clinical alarm management market is expected to reach US$ 6.2 billion by 2033, recording a 7.5% CAGR during the forecast period (2023 to 2033). Alarms alert personnel when a situation is dangerous or life-threatening and requires immediate attention; nevertheless, they regularly sound even when no such scenario exists. Most non-urgent alarms do not require …
Lab Automation Market is expected to surpass US$ 5.5 billion by 2033, at a CAGR 10.1%
During the forecast period, the lab automation market is expected to register a CAGR of 10.1%. The market is anticipated to grow from a valuation of USD 2.1 billion in 2023 to USD 5.5 billion by 2033. Research and Innovations Aid Market Growth The market is secured by steady demand for pharmaceutical research. In addition, …
Sports Medicine Market is expected to reach US$ 11.4 Billion by 2032
In 2022, the worldwide sports medicine market is anticipated to be worth US$ 6.8 billion. Growing at a 5.3% CAGR, it will reach US$ 11.4 billion by 2032. According to the analysis, body reconstruction products would command a market share of approximately 81.3% in 2021. Sports medicine is a rapidly expanding healthcare specialty because the …
Continue reading “Sports Medicine Market is expected to reach US$ 11.4 Billion by 2032”
Continuous Renal Replacement Therapy Market is likely to grow at a CAGR of 7.7% through 2027
The global Continuous Renal Replacement Therapy market was worth US$ 1 Billion in the year 2021 and is poised to reach US$ 1.68 Billion by the year 2027 at a CAGR of 7.7% between 2021 and 2027. Continuous Renal Replacement Therapy is inclusive of removal of solute from the blood through hemofiltration or hemodialysis or …
Pelvic Cancer Induced Hemorrhegic Cystitis Market to expand at an 18.01% value CAGR by 2033
According to Future Market Insights, the global pelvic cancer induced hemorrhagic cystitis market size is estimated to achieve an amazing valuation of US$ 2.1 billion in 2023 and reach US$ 11 billion by 2033, at a CAGR of 18.01%. Rising awareness among the population regarding early treatment and diagnosis for related disorders, coupled with the …
Cytogenetic Systems Market is expected to reach US$ 5,327.8 Million By 2032 at a CAGR of 11.0 %
Global Cytogenetic Systems Market demand is anticipated to be valued at US$ 1,688.5 Million in 2022, forecast to grow at a CAGR of 8.5% to be valued at US$ 5,327.8 Million from 2022 to 2032. Growth is attributed to the increase in incidence of genetic disorders and cancer. The major techniques of cytogenetic testing include fluorescence in-situ hybridization, multiplex-fluorescence in situ hybridization, comparative …